Patient baseline demographics; results are number (%) unless otherwise stated
| Total (n=29) | Thrombolysis (n=15) | No thrombolysis (n=14) | |
|---|---|---|---|
| There were no significant differences for any of the variables. | |||
| JVP, jugular vein pulse. | |||
| Mean (SD) age (years) | 68 (7.6) | 69 (6.6) | 67.5 (8.6) |
| Male | 21 (72) | 12 (80) | 9 (64) |
| Myocardial infarction | |||
| Anterior | 14 (48) | 8 (53) | 6 (43) |
| Inferior | 15 (15) | 7 (47) | 8 (57) |
| Previous myocardial infarction | 5 (17) | 3 (20) | 2 (14) |
| Risk factor | |||
| Smoker | 7 (24) | 2 (14) | 5 (33) |
| Diabetic | 6 (21) | 4 (27) | 2 (14) |
| Hyperlipidaemia | 7 (24) | 3 (20) | 4 (29) |
| Hypertension | 12 (41) | 5 (33) | 7 (50) |
| Family history | 11 (35) | 7 (47) | 4 (29) |
| Previous angina | 2 (7) | 2 (13) | 0 |
| Examination | |||
| Blood pressure ≤90 mm Hg | 13 (45) | 7 (47) | 6 (43) |
| Pulse >100 beats/min | 18 (62) | 8 (53) | 10 (71) |
| Raised JVP | 16 (55) | 6 (40) | 10 (71) |
| Medication | |||
| β-Blocker | 4 (14) | 4 (14) | 0 |
| Calcium blocker | 6 (21) | 3 (20) | 3 (21) |
| Ace inhibitor | 8 (28) | 2 (13) | 6 (43) |
| Diuretic | 13 (45) | 5 (33) | 8 (57) |
| Aspirin | 25 (86) | 13 (86) | 12 (86) |
| Nitrate | 4 (14) | 2 (14) | 2 (13) |
| Inotropes | 29 (100) | 15 (100) | 14 (100) |
| Statin | 3 (10) | 1 (7) | 2 (14) |
| Heparin | 4 (14) | 1 (7) | 3 (21) |